REQUEST A DEMO
Total
USD $0.00
Search more companies

St Pharm Co., Ltd. (Siheung) (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: St Pharm Co., Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

ST Pharm Co.,Ltd is a manufacturer of RNA based drugs and offers custom manufacturing services for active pharmaceutical ingredient and intermediates in compliance to cGMP. The company specializes in small molecular new drugs and technically challenging brand generics, and has developed technologies such as simulated moving bed and continuous flow technology. ST Pharm has expanded into mRNA business and has established two biotechs in the US. The company has a strong background in gene therapy CDMO from oligonucleotide to xRNA and provides expert cGMP manufacturing services from the development stage to commercial scale. ST Pharm's target market includes pharmaceutical development and commercialization.

Headquarters
231, Hyeopryeok-Ro, Siheung-Si, Gyeonggi-Do
Siheung; Gyeonggi;

Contact Details: Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.

Website: http://www.stpharm.co.kr

Basic Information
Total Employees:
Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Outstanding Shares:
Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Registered Capital:
Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Financial Auditors:
Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Incorporation Date:
August 18, 2008
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
32.7%
Purchase this report to view the information.
15.3%
Purchase this report to view the information.
6.4%
Subsidiaries
Dong-A Socio Holdings Co.,Ltd.
Dong-A St Co.,Ltd.
Company Performance
Financial values in the chart are available after St Pharm Co., Ltd. (Siheung) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
28.2%
Total Operating Revenue
28.36%
Operating Profit
756.41%
EBITDA
110.02%
Net Profit/Loss for the Period
17.56%
Total Assets
9.24%
Total Equity
13.81%
Operating Profit Margin
11.89%
Net Profit Margin
-1.05%
Return on Equity (ROE)
0.13%
Debt / Equity
-10497%
Quick Ratio
-996.09%
Cash Ratio
-0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?